EUVIMEDEUVIMED entdecken
Crossref

Serum prolidase in myocardial infarction: purification, kinetic properties, and drug-enzyme interactions

Lana Abid Mansor Alnajar, Ahmed Hassan Kudhair, Ansam Faeq Nouman, Ebaa Adnan Azooz

New Journal of Chemistry · 2026 · 50 (22) · 9605-9616

DOI: 10.1039/d5nj05027h ↗

Kurz gefasst

Fachartikel in der Zeitschrift New Journal of Chemistry, 2026. Verfasst von Lana Abid Mansor Alnajar und 3 weiteren Autor:innen. Die Arbeit nennt 50 Literaturangaben.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

This study focused on the isolation, purification, and biochemical characterization of the prolidase from the serum of patients with myocardial infarction (MI), alongside an in silico evaluation of potential pharmaceutical inhibitors.

Zitieren

APA

Alnajar, L. A. M., Kudhair, A. H., Nouman, A. F., & Azooz, E. A. (2026). Serum prolidase in myocardial infarction: purification, kinetic properties, and drug-enzyme interactions. New Journal of Chemistry, 50(22), 9605-9616. https://doi.org/10.1039/d5nj05027h

Vancouver

Alnajar LAM, Kudhair AH, Nouman AF, Azooz EA. Serum prolidase in myocardial infarction: purification, kinetic properties, and drug-enzyme interactions. New Journal of Chemistry. 2026;50(22):9605-9616. doi:10.1039/d5nj05027h

BibTeX
@article{Alnajar2026,
  author = {Alnajar, Lana Abid Mansor and Kudhair, Ahmed Hassan and Nouman, Ansam Faeq and Azooz, Ebaa Adnan},
  title = {Serum prolidase in myocardial infarction: purification, kinetic properties, and drug-enzyme interactions},
  journal = {New Journal of Chemistry},
  year = {2026},
  volume = {50},
  number = {22},
  pages = {9605--9616},
  doi = {10.1039/d5nj05027h}
}
Kostenlos starten →